了解埃索诺菲尔和慢性阻塞性肺病之间的关系. 一个新的黎明?
1Respiratory Medicine Unit and NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Expert review of respiratory medicine
|December 8, 2025
概括
2型炎症是治疗慢性阻塞性肺病 (COPD) 的关键目标. 精准医学方法,包括生物药物,通过向这种炎症来改善COPD治疗.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个主要的全球健康负担,其特点是不可逆转的气流阻塞.
- 呼吸道炎症,特别是乙酸性或2型炎症,是COPD病原发生的关键因素.
- 在特定的COPD患者群体中,2型炎症越来越被认为是可治疗的目标.
研究的目的:
- 审查2型炎症在COPD病变发生中的作用.
- 讨论针对COPD2型炎症的当前和未来治疗策略.
主要方法:
- 文献综述侧重于COPD中的2型炎症.
- 对精准医学方法和生物标志物导向疗法的分析.
- 检查当前和新兴的生物治疗方法.
主要成果:
- 使用2型生物标志物的精密医学,已经改进了COPD中吸入性皮质类固醇的使用,提高了治疗效率和安全性.
- 首个针对COPD2型炎症的生物疗法已获得批准.
- 以生物标志物为导向的早期干预措施对预防COPD进展越来越感兴趣.
结论:
- 2型炎症是COPD管理中的重要治疗目标.
- 生物标志物引导的精密医学,包括生物药物,为患有2型炎症的COPD患者提供了改善的治疗结果.
- 未来的研究重点是早期干预策略,以防止COPD的发展和进展.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:26Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
01:26COPD: Management Using Bronchodilators and Corticosteroids
705
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
705
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K